Posted by Michael Wonder on 18 Dec 2017
Time for big pharma to step up before the drug price debate rises again
18 December 2017 - In today’s social and political climate, public opinion and public action can galvanise and turn on an issue in an instant.
We’re seeing it right now as the personal misconduct of public figures eviscerates careers and upends personal lives. We saw something similar on the political front happen not too long ago in healthcare when the Affordable Care Act (Obamacare) was up for repeal earlier in the year and congressional town halls were flooded with agitated constituents flogging their GOP representatives.
During the 2016 election cycle, the cost of drugs took centre stage repeatedly between Martin Shkreli, Mylan Pharmaceuticals and the EpiPen price hikes, and Hillary Clinton’s Tweet that rattled the markets.
